S&P Futures
3,915.25 -56.50 (-1.42%) Dow Futures
31,517.00 -322.00 (-1.01%) Nasdaq Futures
11,793.00 -242.25 (-2.01%) Russell 2000 Futures
1,770.10 -21.70 (-1.21%) Crude Oil
109.85 -0.44 (-0.40%) Gold
1,854.90 +7.10 (+0.38%)
PainReform Ltd. (PRFX)
Chart Events
Performance Outlook
| Previous Close | 0.7500 |
| Open | 0.8500 |
| Bid | 0.8027 x 1100 |
| Ask | 0.8751 x 2200 |
| Day's Range | 0.7500 - 0.8966 |
| 52 Week Range | 0.7050 - 7.8400 |
| Volume | |
| Avg. Volume | 88,248 |
| Market Cap | 8.952M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.6860 |
| Earnings Date | Nov 16, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.00 |
- GlobeNewswire
PainReform Provides Business Update for the First Quarter of 2022
Reports successful batch manufacturing of PRF-110 and continued progress towards commencing Phase 3 clinical trials in the second half of 2022TEL AVIV, Israel, May 17, 2022 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, yesterday provided a business update for the first quarter ended March 31, 2022. Ilan Hadar, Chief Executive Officer of Pain Reform, st
- GlobeNewswire
PainReform to Present at The Noble Capital Markets' Eighteenth Annual Investor Conference on April 20th
TEL AVIV, Israel, April 12, 2022 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced that Ilan Hadar, Chief Executive Officer of PainReform will present at the Noble Capital Markets’ Eighteenth Annual Investor Conference being held on April 20-21, 2022 at the Hard Rock Hotel & Casino in Hollywood, Florida. Mr. Hadar will present on Wednesday, April 20th at 12:00 pm Eastern
- GlobeNewswire
PainReform to Present at the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th - 30th
TEL AVIV, Israel, March 21, 2022 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced it will present at the 2022 Virtual Growth Conference, presented by Maxim Group LLC and hosted by M-Vest, on March 28th - 30th from 9:00 a.m. - 5:00 p.m. EDT. The conference will feature roundtable discussions, fireside chats, and multiple company presentatio
